That is essential, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (future report). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a development practically nobody noticed. But it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown prediction for 2021). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back maybe substantially before going higher - angel investor. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. However that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown tech stock 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous great private companies on the edge of striking the general public markets And I've been working on a brand-new way for you to invest even prior to these business go public.
This chance has been building over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your spot for free.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our normal beat (exponential growth). And when it concerns tech investing, we leave it to the specialists. Luckily, we have a number of such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (longtime readers). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and anticipate what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and creating extraordinary chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown 2021 stock picks. But regardless of what many readers may believe, this is a trend that's simply getting begun. Even though the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (future report). Losing two months of production and sales truly affects how numerous 5G gadgets are sold in the calendar year. When you think about all of that, selling 250 million units is impressive. More notably, the delays triggered by the pandemic produced a lots of suppressed need. Which need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown biotech pick. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services start to be provided (biotech stocks jeff brown). That's when we begin to see applications running on 5G networks. Consider things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summer. This begins something of a virtuous cycle: The majority of people don't really care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of amazing applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be massive. Stepping far from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually only 3 companies operating in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is effectively a greenfield opportunity.
There's space for numerous business to exist in this space. jeff brown prediction for 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can precisely forecast the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential because the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been an experimental procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug therapies produced utilizing this technology. This was among those developments that practically no one observed. However it's going to have extensive ramifications for curing disease. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly substantially prior to going greater. I've been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - jeff brown 1 biotech. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. second wave. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date as of February 2021, however we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to select winning technology stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares much of his best choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully anticipated some of the biggest economic occasions of the previous 20 years. Although he doesn't appear to launch his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right every time, but Jeff Brown's accurate forecasts have actually earned him legions of devoted fans. That says a lot about his ability. The Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research provides a number of research services with a wide range of specializations - jeff brown market predictions.
The company is also associated with Bonner & Partners, another well-respected research publisher - jeff brown investment prediction. On its site, Brownstone states its objective is to provide retail investors with professional-grade research: "For too long, the very best financial investment research study has not been readily available to private investors. It has actually been generally reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. the legacy report prediction. The mission of Brownstone Research study is to make that kind of proprietary research available to any investors seeking to acquire an edge in the markets. The goal is basic to deliver distinct and lucrative financial investment research found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. jeff brown top biotech stock 2021. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown thinks S.A.V. jeff brown latest prediction. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: expert system and electrical vehicles. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving cars ever. It's nothing except the automotive market's Holy Grail. As you know, electrical automobiles and self-driving cars and truck stocks have been substantial this year, however the Wall Street device has been huge on buzz without much tangible result. In spite of an extreme increase in competition over the previous few years, Brown still thinks Musk has the very best chance of putting everything together.
tech could be the magic string that ties everything together. S.A.V. represents Shared Autonomous Lorry, and it might be the future of transport. Essentially, this innovation would enable you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You just leave the vehicle and press a button on an app that tells the car to "join the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds crazy, but it could be closed than you think.